Challenger Rejects Daiichi Life’s $4.4 Billion Takeover Offer

Challenger rejects Daiichi Life’s $4.4 billion takeover offer

Daiichi Life's Australian unit last week offered to buy the remaining 79.5% of Challenger at 11.80 Australian dollars per share.

Challenger and suitor Daiichi tango as investors demand higher offer

Daiichi’s bid to extract the annuities company from the ASX has some way to play out because investors want a bid of at least $13 per share, or $8.7 billion.

Challenger earnings: Board responds to indicative offer

Challenger's board has rejected the $11.80 per share offer from TAL Daiichi Life Australia, citing the company’s value and prospects.

Challenger Declines TAL Takeover Offer

Challenger says the non-binding and conditional indicative offer from TAL to acquire the remaining ordinary shares in Challenger it does not already own, is not at a level it could recommend to shareholders. Challenger says in a statement that its Board “…has met and carefully considered the offer, having regard to Challenger’s value and prospects. […]

Will Challenger (ASX:CGF) Engage With Daiichi's Offer?

Challenger Limited received a conditional Daiichi Life takeover approach; shares surged as the board weighs the indicative proposal.

Challenger rejects $7.8bn takeover offer

Challenger's board has rejected a proposed $7.8 billion takeover by TAL Daiichi Life Australia, saying the $11.80 per share offer falls short of a level it could recommend to shareholders.